Integra Therapeutics
Business Services · Spain · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Av. Diagonal 601 Fl 8, Barcelona, Catalo...Website
www.integra-tx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Integra Therapeutics
Integra Therapeutics is a biotechnology company focused on developing advanced gene writing tools to enhance the efficiency and safety of gene therapies. Their primary technology platform, FiCAT (Find and Cut-And-Transfer), addresses key limitations in gene therapy, including gene size, precision, and stability. FiCAT combines the precision of CRISPR-Cas systems with the efficient transfer capabilities of engineered piggyBac transposase proteins, enabling the delivery of both small and large genetic payloadsExplore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Integra Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Integra Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Integra Therapeutics
Integra Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Integra Therapeutics launches new products
Earning: See what the market has to say on Integra Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Integra Therapeutics has new funding data
Click to see if Integra Therapeutics had a recent Job posting/layoffs
Check if Integra Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Integra Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Integra Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Integra Therapeutics.
Integra Therapeutics financials insights
Gather financial insights about Integra Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$6.6M
2025
Other Financing Round
$12.5M
Integra Therapeutics Tech Stack
A closer look at the technologies used by Integra Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Funding
Funding
Person-Based
Person-Based
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Integra Therapeutics News & Media
Integra Therapeutics announces new pre-clinical data at 28th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT)
BARCELONA, Spain, May 13, 2025 /PRNewswire/ -- Integra Therapeutics, a global leader in creating cutting-edge gene-writing tools to improve the efficacy, precision and safety of advanced therapies, today announced it will be presenting new pre-clinical data at the 28th Annual Meeting of...Integra Therapeutics receives EIC Accelerator funds of up to €10.5M for gene writing tools
Biotech Integra Therapeutics, creator of gene writing tools to make advanced therapies safer and more effective, has been awarded up to €10.5 million from the EU via the European Innovation Council (...Integra Therapeutics to Receive Up To €10.5M from European Commission
Integra Therapeutics, a Barcelona, Spain-based company which specializes in gene writing tools, received up to €10.5M from European Commission via the European Innovation Council (EIC) Accelerator program The company intends to use the funds to launch its first gene therapy to treat a serious pediatric hepatic disease, among other activities. In parallel, the company will […] The post Integra Therapeutics to Receive Up To €10.5M from European Commission appeared first on FinSMEs.Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
EAGAN, Minn., March 30, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a science-driven company on the leading edge of oncology drug discovery and development, today announces it is partnering with Integra Therapeutics, a company focused on engineering the next generation of gene writing tools to cure diseases.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Integra Therapeutics
Sign Up For FreeTo access detailed company insights
Integra Therapeutics is a biotechnology company focused on developing advanced gene writing tools to enhance the efficiency and safety of gene therapies. Their primary technology platform, FiCAT (Find and Cut-And-Transfer), addresses key limitations in gene therapy, including gene size, precision, and stability. FiCAT combines the precision of CRIS... Read More
